Successful Completion of Planned DSMB Review of DFU Trial
Filed with ASX · · 2 pages · English
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Grant Award to Fund Study of Cynata MSCs in Heart Disease
- Pipeline Update Following Strategic Portfolio Review
- Further data supports potency of Cynata MSCs
- FDA Clears Cynata IND for Phase 2 Trial in GvHD
- Notice of Allowance for Cynata Chinese Patent
Later from Cynata Therapeutics
- Notice of Allowance for Australia & Canada Cymerus Patents
- New Kidney Transplantation Clinical Trial for Cynata & LUMC
- Notice of Allowance for Cynata US Patent
- Cynata Receives $1.65m R&D Tax Incentive Refund
- Notice of Acceptance for Cynata Australian Patent
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics